NOX provides update to Nyrada Note Holders  
 
    NOX Appendix 4D Half-year report  
 
    NOX Appendix 4C – December 2018 Quarter  
 
    December 18 Nyrada Update  
 
    NOXOPHARM 2018 Annual General Meeting Presentations  
 
    NOX releases latest corporate presentation  
 
    Appendix 4C – September 2018 Quarter  
 
    Noxopharm Releases Report on Key Progress of Subsidiary Nyrada  
 
    Annual Report to shareholders  
 
    Noxopharm Subsidiary Nyrada Announces Important Drug Discovery  
 
    Appendix 4E - Preliminary final report  
 
    AFR 30 August 2018 : Advances in Biotech - Lower cholesterol treatment breakthrough  
 
    Nyrada- key progress with cholesterol-lowering drug candidate  
 
    Appendix 4C – June 2018 Quarter  
 
    Nyrada, Inc. Newsletter 2. April 2018  
 
    Half Year Financial Statement- 31 December 2017  
 
    Appendix 4D - Half-Year Report  
 
    Noxopharm Closes $4M Capital Raising for its US Subsidiary, Nyrada,Inc.  
 
    APPENDIX 4C - DEC 2017 QUARTER  
 
    Nyrada,Inc. Newsletter 1. Jan/Feb 2018  
 
    Nyrada Inc. Information Memorandum Convertible Notes  
 
    NOX Open Briefing Corporate Presentation  
 
    Nyrada Inc. Opens Capital Raise Memorandum Released  
 
    Identification of NYX-104, a promising lead candidate for the treatment of stroke and other excitotoxicity- associated disorders.  
 
    NYX-104 delivers Key Proof of Concept in Stroke Animal Model  
 
    NOX AGM Corporate Presentation  
 
    Completion of Transfer of Sharesto Nyrada Inc.  
 
    Results of General Meeting (“EGM”) of Members – 6 November 2017  
 
    EGM presentations  
 
    NOX/UNSW collaboration confirms drug designed to help stroke victims  
 
    Appendix 4C - Quarterly report for the quarter ended September 30, 2017  
 
    US biotech to develop Australian science  
 
    Annual Report to shareholders  
 
    October 19th Open Briefing Corporate Presentation  
 
    Establishment of Nyrada Inc. - Extraordinary General Meeting  
 
    Establishment of Nyrada Inc.  
 
    Noxopharm and UNSW combine on stroke project